Plasma Exchange for Immune Checkpoint Inhibitor–Induced MyocarditisNovel Teaching Points

Plasma Exchange for Immune Checkpoint Inhibitor–Induced MyocarditisNovel Teaching Points

Immune checkpoint inhibitor therapy has been shown to improve outcomes across many types of malignancies. However, immune checkpoint inhibitor has been associated with several immune-related adverse events including myocarditis. We describe the case of a 69-year-old man with fulminant myocarditis li...

Full description

Bibliographic Details
Main Authors: Haran Yogasundaram, MD, Waleed Alhumaid, MBBS, June W. Chen, BScPharm, ACPR, Matthew Church, MD, Naji Alhulaimi, MBBS, FRCPC, Shane Kimber, MD, FRCPC, D. Ian Paterson, MD, FRCPC, Janek M. Senaratne, MD, FRCPC, FACC
Format: Article
Language:English
Published: Elsevier 2021-03-01
Series:CJC Open
Online Access:http://www.sciencedirect.com/science/article/pii/S2589790X20301888

Internet

http://www.sciencedirect.com/science/article/pii/S2589790X20301888

Similar Items